Archived articles

Psilocybin

Q+A
The path forward for legal medical mushrooms
Published Dec 2, 2020
Johns Hopkins researcher Matthew Johnson discusses the future for psychedelics research in light of Oregon's measure to legalize psilocybin for clinical use
Psychedelics
Inside a psilocybin playlist
Published Nov 11, 2020
Researchers rely on this carefully selected classical and contemporary music playlist to enhance the psychedelic experience for their patients during psilocybin studies
Depression
Psychedelic treatment with psilocybin shown to relieve major depression
Published Nov 11, 2020
The antidepressant effect of the psilocybin—the active compound in so-called magic mushrooms—was about four times greater than is typically seen in traditional antidepressants currently on the market
Drug policy
Scientists recommend reclassifying drug in 'magic' mushrooms
Published Sept 26, 2018
Psilocybin safety and abuse research shows that the drug has low potential for abuse and dependence, researchers say
Hallucinogens
Bad trips, revisited
Published Jan 4, 2017
Study explores the enduring positive, negative consequences of ingesting 'magic mushrooms'
Hallucinogen eases depression, anxiety in cancer patients
Published Dec 1, 2016
In small study, psilocybin, the active compound in 'magic mushrooms,' increased life satisfaction among patients with life-threatening cancer / Johns Hopkins Medicine
Nonfiction
Psychoactive psychology
Published Spring 2016